Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ReproCELL Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ReproCELL Inc, Medical Devices Deals, 2012 to YTD 2018 10
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ReproCELL Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 13
Stemgent Completes Acquisition Of Human Tissue Business From Asterand For US$9 Million 14
Venture Financing 15
Kringle Pharma Raises USD5.4 Million in Venture Financing 15
Reinnervate Secures USD0.16 Million in Venture Funding 17
Reinnervate Secures USD1.72 Million in Venture Funding 18
Stemgent Raises US$11.3 Million In Venture Financing 19
Stemgent Raises US$6.3 Million In Series C Financing 20
Partnerships 21
Q Therapeutics Forms Joint Venture with REPROCELL 21
Q Therapeutics Announces Research Agreement with ReproCELL 22
ReproCELL and Fox Chase Cancer Center Enter into Partnership 23
n3D Biosciences Enters into Distribution Agreement with ReproCELL for Three-Dimensional Bioprinting Product Lines 24
n3D Biosciences Enters into Distribution Agreement with ReproCELL for Cell Culture Products 25
ReproCELL Enters Into Distribution Agreement With Laboratorios Conda 26
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 27
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 28
Reinnervate Enters Into Co-Development Agreement With Kirkstall 29
Licensing Agreements 30
ReproCELL Receives Rights of Stemchymal Cell Therapy Technology from Steminent Biotherapeutics 30
Stemgent Enters Into Licensing Agreement With iPS Academia For Induced Pluripotent Stem Cell Patent Portfolio 31
Equity Offering 32
ReproCELL Completes IPO For US$20.8 Million 32
Asset Transactions 34
ReproCELL to Sell ReproHP Medium 34
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 35
Acquisition 36
ReproCELL Acquires BioServe Biotech from Cancer Genetics for USD1.9 Million 36
ReproCELL Plans to Acquire 7.44% Stake in ReproCELL USA 37
ReproCELL to Acquire Biopta for USD8.2 Million 38
ReproCELL Acquires BioServe Biotechnologies 40
ReproCELL Acquires Reinnervate 41
ReproCELL Inc – Key Competitors 42
ReproCELL Inc – Key Employees 43
ReproCELL Inc – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 45
Recent Developments 46
Other Significant Developments 46
Jun 21, 2018: Human Tissue Experts REPROCELL Launch New Customized Primary Cell Isolation Services 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
ReproCELL Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ReproCELL Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ReproCELL Inc, Deals By Therapy Area, 2012 to YTD 2018 9
ReproCELL Inc, Medical Devices Deals, 2012 to YTD 2018 10
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 13
Stemgent Completes Acquisition Of Human Tissue Business From Asterand For US$9 Million 14
Kringle Pharma Raises USD5.4 Million in Venture Financing 15
Reinnervate Secures USD0.16 Million in Venture Funding 17
Reinnervate Secures USD1.72 Million in Venture Funding 18
Stemgent Raises US$11.3 Million In Venture Financing 19
Stemgent Raises US$6.3 Million In Series C Financing 20
Q Therapeutics Forms Joint Venture with REPROCELL 21
Q Therapeutics Announces Research Agreement with ReproCELL 22
ReproCELL and Fox Chase Cancer Center Enter into Partnership 23
n3D Biosciences Enters into Distribution Agreement with ReproCELL for Three-Dimensional Bioprinting Product Lines 24
n3D Biosciences Enters into Distribution Agreement with ReproCELL for Cell Culture Products 25
ReproCELL Enters Into Distribution Agreement With Laboratorios Conda 26
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 27
Reinnervate Enters Into Co-Development Agreement With Roslin Cellab 28
Reinnervate Enters Into Co-Development Agreement With Kirkstall 29
ReproCELL Receives Rights of Stemchymal Cell Therapy Technology from Steminent Biotherapeutics 30
Stemgent Enters Into Licensing Agreement With iPS Academia For Induced Pluripotent Stem Cell Patent Portfolio 31
ReproCELL Completes IPO For US$20.8 Million 32
ReproCELL to Sell ReproHP Medium 34
ReproCELL Acquires Induced Pluripotent Stem Cell Business from Stemgent for USD8.5 Million 35
ReproCELL Acquires BioServe Biotech from Cancer Genetics for USD1.9 Million 36
ReproCELL Plans to Acquire 7.44% Stake in ReproCELL USA 37
ReproCELL to Acquire Biopta for USD8.2 Million 38
ReproCELL Acquires BioServe Biotechnologies 40
ReproCELL Acquires Reinnervate 41
ReproCELL Inc, Key Competitors 42
ReproCELL Inc, Key Employees 43
ReproCELL Inc, Other Locations 44
ReproCELL Inc, Subsidiaries 44
ReproCELL Inc, Joint Venture 45
List of Figures
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ReproCELL Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ReproCELL Inc, Medical Devices Deals, 2012 to YTD 2018 10